Get the Stockscreener App
0.0068
8.11%
-0.0006
Pharmadrug Inc Stock (LMLLF) Forecast
The Pharmadrug Inc (LMLLF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.0266, representing a +291.80% increase from the current price of $0.0068. The highest analyst price target is $0.0266, and the lowest is $0.0266.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LMLLF Price Target
Average 0.0368
(+441.83% Upside)
Long-term LMLLF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pharmadrug Inc financial reports and earnings history, Pharmadrug Inc (LMLLF) stock could reach $0.1069 by 2030, $0.3348 by 2040 and $0.339 by 2050. See the projected annual prices until 2050 of the Pharmadrug Inc stock below:
- Pharmadrug Inc (LMLLF) is expected to reach an average price of $0.2006 in 2035, with a high prediction of $0.2136 and a low estimate of $0.2029. This indicates an $2,850% rise from the last recorded price of $0.0068.
- Pharmadrug Inc (LMLLF) stock is projected to chart a bullish course in 2040, with an average price target of $0.3114, representing an $4,479% surge from its current level. The forecast ranges from a conservative $0.3114 to a sky-high $0.3348.
- Our analysts predict Pharmadrug Inc (LMLLF) to jump 6,282% by 2045, soaring from $0.2395 to an average price of $0.434, potentially reaching $0.4543. While $0.2395 is the low estimate, the potential upside is significant.
- Pharmadrug Inc (LMLLF) stock is expected to climb by 2050, reaching an average of $0.3178, a $4,574% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.339 and $0.2967, respectively, highlighting the market's uncertainty.
Pharmadrug Inc Stock (LMLLF) Year by Year Forecast
Pharmadrug Inc Stock (LMLLF) Price Forecast for 2025
Pharmadrug Inc Stock (LMLLF) is expected to reach an average price of $0.0293 in 2025, with a high prediction of $0.0427 and a low estimate of $0.016. This indicates an +331.55% rise from the last recorded price of $0.0068.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $0.0266 | $0.0266 | $0.0266 | +291.06% |
| August, 2025 | $0.0236 | $0.0238 | $0.0232 | +247.65% |
| September, 2025 | $0.0428 | $0.0212 | $0.0427 | +530.14% |
| October, 2025 | $0.0386 | $0.0386 | $0.0388 | +467.60% |
| November, 2025 | $0.0385 | $0.0356 | $0.0344 | +466.10% |
| December, 2025 | $0.0329 | $0.0379 | $0.0368 | +383.70% |
Pharmadrug Inc Stock (LMLLF) Price Forecast for 2026
The predicted value for Pharmadrug Inc (LMLLF) in 2026 is set at an average of $0.0443. Estimates vary from a peak of $0.0623 to a trough of $0.0264, indicating an +552.11% surge from the present price of $0.0068.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0304 | $0.0324 | $0.0334 | +346.90% |
| February, 2026 | $0.0276 | $0.0278 | $0.029 | +305.69% |
| March, 2026 | $0.0474 | $0.0264 | $0.0525 | +597.03% |
| April, 2026 | $0.046 | $0.0442 | $0.0464 | +577.14% |
| May, 2026 | $0.0448 | $0.0465 | $0.0445 | +558.72% |
| June, 2026 | $0.0398 | $0.0402 | $0.0442 | +485.14% |
| July, 2026 | $0.0352 | $0.0354 | $0.0348 | +418.19% |
| August, 2026 | $0.062 | $0.0316 | $0.0623 | +812.49% |
| September, 2026 | $0.0562 | $0.0562 | $0.0576 | +726.42% |
| October, 2026 | $0.0545 | $0.0528 | $0.0516 | +701.37% |
| November, 2026 | $0.0469 | $0.0522 | $0.0523 | +589.55% |
| December, 2026 | $0.0428 | $0.0448 | $0.047 | +529.21% |
Pharmadrug Inc Stock (LMLLF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pharmadrug Inc (LMLLF) is $0.0593, with a high forecast of $0.0819 and a low forecast of $0.0368. This indicates an +772.67% increase from the last price of $0.0068.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0384 | $0.0386 | $0.0406 | +464.46% |
| February, 2027 | $0.0674 | $0.0368 | $0.0721 | +891.15% |
| March, 2027 | $0.0628 | $0.0614 | $0.064 | +824.18% |
| April, 2027 | $0.06 | $0.0617 | $0.0601 | +782.22% |
| May, 2027 | $0.053 | $0.0538 | $0.059 | +679.22% |
| June, 2027 | $0.0468 | $0.047 | $0.0469 | +588.73% |
| July, 2027 | $0.0878 | $0.042 | $0.0819 | +1,191% |
| August, 2027 | $0.0738 | $0.0738 | $0.0764 | +985.23% |
| September, 2027 | $0.0705 | $0.07 | $0.0688 | +936.64% |
| October, 2027 | $0.0635 | $0.0667 | $0.0679 | +833.50% |
| November, 2027 | $0.0552 | $0.0572 | $0.0606 | +711.52% |
| December, 2027 | $0.0492 | $0.0494 | $0.0522 | +623.23% |
Pharmadrug Inc Stock (LMLLF) Price Forecast for 2028
In 2028, Pharmadrug Inc (LMLLF) is projected to reach an average price of $0.0792, with a high projection of $0.1113 and a low estimate of $0.0472. This indicates an +1,065% rise from the last price of $0.0068.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0842 | $0.0472 | $0.0917 | +1,138% |
| February, 2028 | $0.0796 | $0.0786 | $0.0816 | +1,071% |
| March, 2028 | $0.0752 | $0.0769 | $0.0757 | +1,006% |
| April, 2028 | $0.0674 | $0.0674 | $0.0738 | +891.69% |
| May, 2028 | $0.0584 | $0.0586 | $0.0649 | +759.26% |
| June, 2028 | $0.1074 | $0.0524 | $0.1015 | +1,479% |
| July, 2028 | $0.0914 | $0.0914 | $0.0952 | +1,244% |
| August, 2028 | $0.0865 | $0.0872 | $0.086 | +1,172% |
| September, 2028 | $0.0779 | $0.0811 | $0.0835 | +1,045% |
| October, 2028 | $0.0676 | $0.0696 | $0.0742 | +893.83% |
| November, 2028 | $0.06 | $0.0602 | $0.0638 | +782.00% |
| December, 2028 | $0.105 | $0.0576 | $0.1113 | +1,444% |
Pharmadrug Inc Stock (LMLLF) Price Forecast for 2029
The 2029 price forecast for Pharmadrug Inc Stock (LMLLF) is $0.0968 on average, with a high prediction of $0.1309 and a low estimate of $0.0628. This represents an +1,324% increase from the previous price of $0.0068.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0964 | $0.0958 | $0.0992 | +1,318% |
| February, 2029 | $0.0904 | $0.0921 | $0.0913 | +1,229% |
| March, 2029 | $0.081 | $0.081 | $0.0886 | +1,092% |
| April, 2029 | $0.07 | $0.0702 | $0.0781 | +929.80% |
| May, 2029 | $0.127 | $0.0628 | $0.1211 | +1,768% |
| June, 2029 | $0.107 | $0.1119 | $0.114 | +1,473% |
| July, 2029 | $0.1025 | $0.1033 | $0.108 | +1,407% |
| August, 2029 | $0.0923 | $0.0955 | $0.0991 | +1,257% |
| September, 2029 | $0.0848 | $0.0851 | $0.088 | +1,147% |
| October, 2029 | $0.0708 | $0.071 | $0.0779 | +940.77% |
| November, 2029 | $0.1238 | $0.068 | $0.1309 | +1,721% |
| December, 2029 | $0.1132 | $0.113 | $0.1172 | +1,565% |
Pharmadrug Inc Stock (LMLLF) Price Forecast for 2030
Pharmadrug Inc Stock (LMLLF) is expected to reach an average price of $0.1118 in 2030, with a high forecast of $0.1505 and a low forecast of $0.0732. This signifies an +1,545% surge from the last price of $0.0068.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.1056 | $0.1073 | $0.1069 | +1,453% |
| February, 2030 | $0.0946 | $0.0946 | $0.1034 | +1,292% |
| March, 2030 | $0.0845 | $0.0845 | $0.0913 | +1,142% |
| April, 2030 | $0.1466 | $0.0732 | $0.1407 | +2,056% |
| May, 2030 | $0.125 | $0.1299 | $0.1332 | +1,738% |
| June, 2030 | $0.1186 | $0.1209 | $0.1256 | +1,645% |
| July, 2030 | $0.1067 | $0.1099 | $0.1147 | +1,469% |
| August, 2030 | $0.0976 | $0.0979 | $0.102 | +1,335% |
| September, 2030 | $0.0816 | $0.0818 | $0.0903 | +1,100% |
| October, 2030 | $0.1426 | $0.0784 | $0.1505 | +1,997% |
| November, 2030 | $0.1298 | $0.1302 | $0.1356 | +1,809% |
| December, 2030 | $0.1208 | $0.1225 | $0.1263 | +1,676% |
5.71%
0.34%
Cap:
|
Volume (24h):